Vivani Medical, Inc.
VANI
$1.22
-$0.025-2.02%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 24.68% | -6.44% | 42.94% | -22.09% | -30.93% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 31.35% | 5.30% | 3.91% | -11.69% | -18.88% |
| Operating Income | -31.35% | -5.30% | -3.91% | 11.69% | 18.88% |
| Income Before Tax | -33.38% | -4.36% | -0.40% | 10.93% | 17.93% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -33.38% | -4.36% | -0.40% | 10.93% | 17.93% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -33.38% | -4.36% | -0.40% | 10.93% | 17.93% |
| EBIT | -31.35% | -5.30% | -3.91% | 11.69% | 18.88% |
| EBITDA | -31.88% | -5.34% | -4.12% | 12.39% | 19.38% |
| EPS Basic | -23.95% | 8.04% | 10.75% | 18.07% | 24.28% |
| Normalized Basic EPS | -24.01% | 8.02% | 10.84% | 18.11% | 24.28% |
| EPS Diluted | -23.95% | 8.04% | 10.75% | 18.07% | 24.28% |
| Normalized Diluted EPS | -24.01% | 8.02% | 10.84% | 18.11% | 24.28% |
| Average Basic Shares Outstanding | 7.68% | 13.47% | 12.54% | 8.67% | 8.32% |
| Average Diluted Shares Outstanding | 7.68% | 13.47% | 12.54% | 8.67% | 8.32% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |